Picard Medical, Inc. (PMI)

Chart not available yet

Data will show when the stock starts trading on Aug 22, 2025.

Market Cap	288.22M
Revenue (ttm)	4.39M
Net Income (ttm)	-23.74M
Shares Out	72.06M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About PMI

Picard Medical owns 100% of the membership interests of SynCardia Systems. SynCardia is a medical technology company that manufactures and sells the only U.S. Food and Drug Administration, and Health Canada approved implantable total artificial heart (the “SynCardia TAH”). To date, over 2,100 SynCardia TAHs have been implanted in patients in 27 countries and the SynCardia TAH is an established bridge to heart transplantation for patients with biventricular failure in the U.S., and around the world.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Aug 22, 2025
• Employees: 75
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: PMI
• Website: https://www.syncardia.com/

Financial Performance

Financial numbers in USD